4th Quarter - Report
EXELIXIS INC. for EXELIXIS INC.
Firm
Client
Income
—
Expenses
$280,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Policies and proposals related to drug pricing, including provisions of the Build Back Better Act and HR 3, the Elijah E Cummings Lower Drug Costs Now Act; and administration of the 340B Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES M. FENTON | — |
| ERIN HERMANCE New | Sr. Legislative Director, Rep. John Katko (2015-2017); and Staff Assistant, House Speaker John Boehner (2011). |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.